Human Stem Cells Institute Balance Sheet Health
Financial Health criteria checks 3/6
Human Stem Cells Institute has a total shareholder equity of RUB486.9M and total debt of RUB505.7M, which brings its debt-to-equity ratio to 103.9%. Its total assets and total liabilities are RUB1.8B and RUB1.3B respectively. Human Stem Cells Institute's EBIT is RUB127.4M making its interest coverage ratio 2.4. It has cash and short-term investments of RUB59.9M.
Key information
103.9%
Debt to equity ratio
₽505.70m
Debt
| Interest coverage ratio | 2.4x |
| Cash | ₽59.91m |
| Equity | ₽486.86m |
| Total liabilities | ₽1.26b |
| Total assets | ₽1.75b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ISKJ's short term assets (RUB583.0M) exceed its short term liabilities (RUB294.3M).
Long Term Liabilities: ISKJ's short term assets (RUB583.0M) do not cover its long term liabilities (RUB969.3M).
Debt to Equity History and Analysis
Debt Level: ISKJ's net debt to equity ratio (91.6%) is considered high.
Reducing Debt: ISKJ's debt to equity ratio has reduced from 236.4% to 103.9% over the past 5 years.
Debt Coverage: ISKJ's debt is well covered by operating cash flow (54.3%).
Interest Coverage: ISKJ's interest payments on its debt are not well covered by EBIT (2.4x coverage).